In silico design and molecular docking study of CDK2 inhibitors with potent cytotoxic activity against HCT116 colorectal cancer cell line
Open Access
- 15 September 2020
- journal article
- research article
- Published by Elsevier in Journal of Genetic Engineering and Biotechnology
- Vol. 18 (1) , 51-12
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- In Silico Drug-Designing Studies on Flavanoids as Anticolon Cancer Agents: Pharmacophore Mapping, Molecular Docking, and Monte Carlo Method-Based QSAR ModelingInterdisciplinary Sciences: Computational Life Sciences, 2016
- Cyclin A2 and CDK2 as Novel Targets of Aspirin and Salicylic Acid: A Potential Role in Cancer PreventionMolecular Cancer Research, 2016
- Adapalene inhibits the activity of cyclin-dependent kinase 2 in colorectal carcinomaMolecular Medicine Reports, 2015
- Targeted inhibition of VEGF receptor 2: an update on ramucirumabExpert Opinion on Biological Therapy, 2013
- Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathwaysEndocrine-Related Cancer, 2012
- Integrating Structure-Based and Ligand-Based Approaches for Computational Drug DesignFuture Medicinal Chemistry, 2011
- Best Practices for QSAR Model Development, Validation, and ExploitationMolecular Informatics, 2010
- Diagnostic accuracy systematic review of rectal bleeding in combination with other symptoms, signs and tests in relation to colorectal cancerBritish Journal of Cancer, 2009
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Computer Aided Design of ExperimentsTechnometrics, 1969